Trexquant Investment’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-148,502
| Closed | -$1.4M | – | 1443 |
|
|
2020
Q3 | $1.4M | Buy |
148,502
+95,975
| +183% | +$907K | 0.09% | 309 |
|
|
2020
Q2 | $471K | Buy |
+52,527
| New | +$471K | 0.03% | 702 |
|
|
2019
Q2 | – | Sell |
-10,392
| Closed | -$99K | – | 1081 |
|
|
2019
Q1 | $99K | Sell |
10,392
-64,281
| -86% | -$612K | 0.01% | 926 |
|
|
2018
Q4 | $857K | Buy |
+74,673
| New | +$857K | 0.05% | 461 |
|
|
2018
Q2 | – | Sell |
-27,862
| Closed | -$529K | – | 1171 |
|
|
2018
Q1 | $529K | Buy |
27,862
+2,072
| +8% | +$39.3K | 0.04% | 612 |
|
|
2017
Q4 | $423K | Buy |
+25,790
| New | +$423K | 0.05% | 581 |
|
|
2017
Q3 | – | Sell |
-82,478
| Closed | -$726K | – | 1005 |
|
|
2017
Q2 | $726K | Buy |
+82,478
| New | +$726K | 0.2% | 138 |
|
|
2016
Q4 | – | Sell |
-15,952
| Closed | -$74K | – | 1119 |
|
|
2016
Q3 | $74K | Buy |
+15,952
| New | +$74K | 0.02% | 699 |
|
|
2016
Q2 | – | Sell |
-36,687
| Closed | -$222K | – | 1070 |
|
|
2016
Q1 | $222K | Buy |
+36,687
| New | +$222K | 0.03% | 819 |
|
|
2015
Q2 | – | Sell |
-36,100
| Closed | -$566K | – | 1212 |
|
|
2015
Q1 | $566K | Sell |
36,100
-47,858
| -57% | -$750K | 0.06% | 645 |
|
|
2014
Q4 | $1.28M | Buy |
+83,958
| New | +$1.28M | 0.23% | 83 |
|